Contact Media Relations
James R. Downing, MD, listed as one of 100 influential people in healthcare in 2023.
Adding a modular chimeric cytokine receptor to CAR T cells increased their efficacy. Learn how this modular system could improve brain and solid tumor therapy.
St. Jude scientists identified 229 genes regulated by undruggable oncogenic HOXA9. Learn how it may lead to better treatments for high risk pediatric leukemias.
GRP78 is a promising CAR T-cell immunotherapy target for brain and solid tumors. Discover why it’s special, including how cancer uses it to trick immune cells.
Find how mapping chromatin accessibility & regulation in pediatric acute lymphoblastic leukemia (ALL) subtypes may uncover therapy response heterogeneity cause.
More than 250 attendees spanning Spanish-language media, celebrities and content creators gathered last weekend for the
St. Jude Promesa y Esperanza seminar.
Thanks and Giving® campaign is celebrating 20 years of bringing together celebrities, businesses and consumers to support
St. Jude Children’s Research Hospital.
This Giving Tuesday, join celebrities like Emma Roberts, content creators like Santa J Claus and communities everywhere to raise funds for
St. Jude Children’s Research Hospital® and their lifesaving mission.
St. Jude is among the top brands engaging communities through culturally relevant and meaningful outreach.
View More News Releases
Get science and medicine updates.
Visit Our Blog
Meet our patients, supporters and staff.
View Our Stories
Follow us for up-to-the-minute news and events at St. Jude.
Connect with Us
Encourage your readers, listeners or viewers to support our lifesaving mission by sharing our PSAs.
Our media relations staff will help you set up interviews, media visits or answer your questions about the hospital. Find a contact for your story >